Literature DB >> 21075313

Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized.

Elsa Quintana1, Mark Shackleton, Hannah R Foster, Douglas R Fullen, Michael S Sabel, Timothy M Johnson, Sean J Morrison.   

Abstract

We investigated whether melanoma is hierarchically organized into phenotypically distinct subpopulations of tumorigenic and nontumorigenic cells or whether most melanoma cells retain tumorigenic capacity, irrespective of their phenotype. We found 28% of single melanoma cells obtained directly from patients formed tumors in NOD/SCID IL2Rγ(null) mice. All stage II, III, and IV melanomas obtained directly from patients had common tumorigenic cells. All tumorigenic cells appeared to have unlimited tumorigenic capacity on serial transplantation. We were unable to find any large subpopulation of melanoma cells that lacked tumorigenic potential. None of 22 heterogeneously expressed markers, including CD271 and ABCB5, enriched tumorigenic cells. Some melanomas metastasized in mice, irrespective of whether they arose from CD271(-) or CD271(+) cells. Many markers appeared to be reversibly expressed by tumorigenic melanoma cells.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21075313      PMCID: PMC3031091          DOI: 10.1016/j.ccr.2010.10.012

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  36 in total

1.  Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.

Authors:  Catriona H M Jamieson; Laurie E Ailles; Scott J Dylla; Manja Muijtjens; Carol Jones; James L Zehnder; Jason Gotlib; Kevin Li; Markus G Manz; Armand Keating; Charles L Sawyers; Irving L Weissman
Journal:  N Engl J Med       Date:  2004-08-12       Impact factor: 91.245

2.  A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

Authors:  Alexander Roesch; Mizuho Fukunaga-Kalabis; Elizabeth C Schmidt; Susan E Zabierowski; Patricia A Brafford; Adina Vultur; Devraj Basu; Phyllis Gimotty; Thomas Vogt; Meenhard Herlyn
Journal:  Cell       Date:  2010-05-14       Impact factor: 41.582

3.  Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder.

Authors:  Katherine I Oravecz-Wilson; Steven T Philips; Omer H Yilmaz; Heather M Ames; Lina Li; Brendan D Crawford; Alice M Gauvin; Peter C Lucas; Kajal Sitwala; James R Downing; Sean J Morrison; Theodora S Ross
Journal:  Cancer Cell       Date:  2009-08-04       Impact factor: 31.743

4.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

5.  A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.

Authors:  Sreenath V Sharma; Diana Y Lee; Bihua Li; Margaret P Quinlan; Fumiyuki Takahashi; Shyamala Maheswaran; Ultan McDermott; Nancy Azizian; Lee Zou; Michael A Fischbach; Kwok-Kin Wong; Kathleyn Brandstetter; Ben Wittner; Sridhar Ramaswamy; Marie Classon; Jeff Settleman
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

6.  Identification and expansion of human colon-cancer-initiating cells.

Authors:  Lucia Ricci-Vitiani; Dario G Lombardi; Emanuela Pilozzi; Mauro Biffoni; Matilde Todaro; Cesare Peschle; Ruggero De Maria
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

7.  A robust xenotransplantation model for acute myeloid leukemia.

Authors:  P V Sanchez; R L Perry; J E Sarry; A E Perl; K Murphy; C R Swider; A Bagg; J K Choi; J A Biegel; G Danet-Desnoyers; M Carroll
Journal:  Leukemia       Date:  2009-07-23       Impact factor: 11.528

8.  Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination.

Authors:  Sophie Pinner; Peter Jordan; Kirsty Sharrock; Laura Bazley; Lucy Collinson; Richard Marais; Elise Bonvin; Colin Goding; Erik Sahai
Journal:  Cancer Res       Date:  2009-10-13       Impact factor: 12.701

9.  Antitumor immunity and cancer stem cells.

Authors:  Tobias Schatton; Markus H Frank
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

10.  Identification of human brain tumour initiating cells.

Authors:  Sheila K Singh; Cynthia Hawkins; Ian D Clarke; Jeremy A Squire; Jane Bayani; Takuichiro Hide; R Mark Henkelman; Michael D Cusimano; Peter B Dirks
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

View more
  254 in total

Review 1.  Systems pathology: a critical review.

Authors:  Jose Costa
Journal:  Mol Oncol       Date:  2011-11-27       Impact factor: 6.603

2.  Transforming growth factor-beta signaling network regulates plasticity and lineage commitment of lung cancer cells.

Authors:  I Ischenko; J Liu; O Petrenko; M J Hayman
Journal:  Cell Death Differ       Date:  2014-03-28       Impact factor: 15.828

Review 3.  Drug rechallenge and treatment beyond progression--implications for drug resistance.

Authors:  Elizabeth A Kuczynski; Daniel J Sargent; Axel Grothey; Robert S Kerbel
Journal:  Nat Rev Clin Oncol       Date:  2013-09-03       Impact factor: 66.675

4.  Eradication of melanomas by targeted elimination of a minor subset of tumor cells.

Authors:  Patrick Schmidt; Caroline Kopecky; Andreas Hombach; Paola Zigrino; Cornelia Mauch; Hinrich Abken
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

Review 5.  Reactive oxygen species in cancer stem cells.

Authors:  Xiaoke Shi; Yan Zhang; Junheng Zheng; Jingxuan Pan
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

Review 6.  Cancer Stem Cells: The Architects of the Tumor Ecosystem.

Authors:  Briana C Prager; Qi Xie; Shideng Bao; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2019-01-03       Impact factor: 24.633

Review 7.  Cancer stem cells and their role in metastasis.

Authors:  Yusuke Shiozawa; Biao Nie; Kenneth J Pienta; Todd M Morgan; Russell S Taichman
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

8.  Lineage Plasticity in Cancer Progression and Treatment.

Authors:  Clémentine Le Magnen; Michael M Shen; Cory Abate-Shen
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

9.  ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit.

Authors:  Brian J Wilson; Karim R Saab; Jie Ma; Tobias Schatton; Pablo Pütz; Qian Zhan; George F Murphy; Martin Gasser; Ana Maria Waaga-Gasser; Natasha Y Frank; Markus H Frank
Journal:  Cancer Res       Date:  2014-06-16       Impact factor: 12.701

Review 10.  Perivascular stem cell niche in head and neck cancer.

Authors:  Kathryn E Ritchie; Jacques E Nör
Journal:  Cancer Lett       Date:  2012-07-25       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.